Ledger.Open graph →
SEC Form D · filed September 5, 2025

Avenzo Therapeutics, Inc

Offering
$75.0M
Sold
$47.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Athena Countouriotis · San Diego, CAExec · DirectorCarl Gordon · San Diego, CADirectorJudith Li · San Diego, CADirectorScott Lipman · San Diego, CAExecMohammad Hirmand · San Diego, CAExecJakob Dupont, M.D., M.A · San Diego, CADirectorGarry Nicholson · San Diego, CADirectorBrian Sun · San Diego, CAExecPaolo Tombesi · San Diego, CAExecSimeon George · San Diego, CADirectorPatrick Machado · New York, NYDirectorPatrick Machado · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗